FOR IMMEDIATE RELEASE
April 7, 2020
CareATC using Jvion’s COVID Patient Vulnerability Lists to Proactively Intervene with High-Risk Patient Populations
Tulsa, OK – April 7, 2020 -- CareATC, a leader in population health management for self-insured employers, is leveraging Jvion’s advanced machine learning capabilities to provide clients the opportunity to use data insights to protect the most vulnerable from the novel coronavirus.
Jvion, a leader in clinical AI, is delivering COVD-19 Patient Vulnerability Lists, which provide insights on individual patient risk to help care providers take proactive action to save lives in their communities.
Supplementing these vulnerability lists, CareATC is offering clients an employee outreach program in which a specialized team of nurses initiate phone calls to those most at risk for a negative outcome, even before exhibiting symptoms, to provide that same education and support proactively.
Leveraging a combination of claims data and publicly available data, the AI-generated lists rank hospital patient populations based on their risk for the most severe outcomes if infected. Patients are classified by their risk of hospitalization, end organ failure, and mortality as a result of infection. The lists also identify the clinical factors and social determinants of health driving their risk, including factors like unemployment, transportation access and food insecurity.
Vickie Rice, VP of Strategic Analytics at CareATC said, “With the output from Jvion’s COVID-19 list, we’ve been able to proactively reach out to those patients in our population who are most vulnerable to COVID-19, while at the same time offering our employer clients the ability to mitigate the impacts of this disease on their population.”
“Health systems can use this information to proactively engage patients with guidance to prevent the worst outcomes, prepare for surges of patients in advance, establish mobile testing centers for vulnerable populations, and to inform partnerships with community groups to address the top socioeconomic contributing factors,” said Dr. John Frownfelter, Chief Medical Information Officer for Jvion. “This could include providing food delivery services if transportation is limited, to protect the vulnerable from leaving their homes,” he added.
In addition to customer-specific patient vulnerability lists, Jvion also released a COVID Community Vulnerability Map, which has received over one million views to date. The map provides a geospatial view of populations at-risk for severe outcomes, and surfaces the socioeconomic and environmental drivers for that risk. It is also overlaid with points of interest such as transportation, food sources, hospitals and health services, helping community leaders and healthcare providers deploy interventions and allocate resources.
CareATC is providing these services at no additional charge to employer partners and patients as part of their contribution to the nationwide efforts in this time of critical need. CareATC is HIPAA-compliant and does not reveal individual patient data. Employers receive an aggregate report to help them measure population risk.
About CareATC, Inc.
CareATC Inc. is a leading innovator in the health technology sector providing on-site and shared-site medical clinics. By leveraging groundbreaking technology, CareATC offers customized population health management solutions for employers that reduce healthcare costs by promoting health, preventing disease and providing a shorter path to care. CareATC manages more than 150 clients in 35 states and cares for more than 300,000 patients. Accredited by the Accreditation Association for Ambulatory Health Care Inc., CareATC is based in Tulsa, Oklahoma. To learn more about CareATC Inc., visit www.careatc.com.
About Jvion
Jvion enables healthcare organizations to prevent avoidable patient harm and lower costs through its AI-enabled prescriptive analytics solution. An industry first, the Jvion Machine goes beyond simple predictive analytics and machine learning to identify patients on a trajectory to becoming high risk and for whom intervention will likely be successful. Jvion determines the interventions that will more effectively reduce risk and enable clinical action. And it accelerates time to value by leveraging established patient-level intelligence to drive engagement across hospitals, populations, and patients. To date, the Jvion Machine has been deployed across about 50 hospital systems and 300 hospitals, who report average reductions of 30% for preventable harm incidents and annual cost savings of $6.3 million. For more information, visit www.jvion.com, or follow Jvion on Linkedin and Twitter.
Jvion PR Contact:Lexi Herosian lexi@scratchmm.com
Media Contact:
Paul Keeling
Phone: (918) 779-7414
Email: pkeeling@careatc.com